Macquarie Group LTD Wave Life Sciences Ltd. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Macquarie Group LTD holds 81,955 shares of WVE stock, worth $679,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,955
Previous 81,955
-0.0%
Holding current value
$679,406
Previous $505,000
19.21%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
146Shares Held
93.1MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$151 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$63.6 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$55.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$51.1 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$44.4 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $720M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...